Havica Tablet 5/20 mg

Adult dose

This medication is administered once daily as a single tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosing is as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine 5 mg or Olmesartan Medoxomil 20 mg monotherapy. - 10/20 mg: Administered to patients with Olmesartan Medoxomil 20 mg monotherapy.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age.

This medication can cause serious harm or even death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be administered to individuals with hypersensitivity to any component of this medication, including pregnant women, nursing mothers, patients with severe liver impairment, severe aortic stenosis, biliary obstruction, patients undergoing dialysis, patients in shock, and certain diabetic patients. In patients with low blood pressure due to inadequate fluid or electrolyte status, hypotensive symptoms may occur, so treatment should be initiated with careful monitoring of their condition. This medication can cause blood vessel dilation, and in rare cases, acute hypotension may occur; therefore, caution is necessary, especially in patients with severe aortic stenosis. Patients with severe obstructive coronary artery disease may experience an increased risk of angina or myocardial infarction when taking this medication, so they should be monitored closely. In patients with congestive heart failure, the use of this medication may exacerbate heart failure, but it can be used with appropriate dose adjustments and monitoring. Patients with impaired renal function may experience deterioration of their kidney function due to this medication, and renal function should be monitored periodically. Patients with impaired liver function may experience slower metabolism and excretion of this medication, necessitating dose adjustments and careful monitoring. Common adverse reactions during treatment may include dizziness, headache, and hypotension, and if symptoms are severe, consultation with healthcare providers is recommended. During pregnancy, this medication may pose a risk to the fetus, so it should be avoided, while nursing mothers should consider discontinuing either the medication or breastfeeding due to potential adverse reactions in infants. Safety and efficacy have not been established for patients under 18 years old, and the use in this population is not recommended. Elderly patients may have altered drug responses due to decreased kidney and liver function, so treatment should start at low doses with careful monitoring. In cases of overdose, severe hypotension and peripheral vascular dilation, tachycardia may occur, necessitating prompt medical attention. This medication should be stored in a tightly closed container to protect it from moisture, heat, and light, and it should be kept out of the reach of children; transferring to another container should be avoided.

Serious side effects

• Hives
• severe swelling (edema)
• breathing difficulties
• difficulty in breathing
• gallstones
• exacerbation of stroke
• gum bleeding
• vascular edema
• acute kidney failure
• hair loss

Mild side effects

• Decreased libido
• dizziness
• headache
• orthostatic hypotension
• drowsiness
• sensory disturbances
• sensory reduction
• syncope
• vertigo
• palpitations

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is important to maintain storage temperatures between 1°C and 30°C to safely preserve the medication's efficacy.

Appearance

White round film-coated tablet

Package unit

28 tablets (14 tablets/PTP X 2)